v3.20.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Operating Activities      
Net loss $ (98,593) $ (19,898) $ (26,199)
Adjustments to reconcile net loss to cash provided by operating activities:      
Amortization and depreciation 76,513 66,401 79,027
Impairment losses 86 0 2,198
Amortization of debt issuance cost and accretion of discount on debt and leases 2,201 1,577 1,148
Stock-based compensation 47,597 32,060 31,721
Deferred income taxes (18,488) (15,693) (12,144)
Loss on disposal of property and equipment 0 46 430
Impairment of leasehold improvements 319 1,442 735
Impairment of leased right-of-use assets 1,508 9,240 0
Gain on extinguishment of lease liabilities 0 (10,437) 0
(Gain) loss on foreign currency and other 1,289 760 (809)
Excess tax benefits on stock-based awards (677) (4,064) (2,028)
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable (16,856) 9,090 6,595
Inventory (31,837) 10,195 11,696
Prepaid expenses and other assets (38,954) 3,805 1,071
Leased right-of-use assets 441 3,044 0
Accounts payable, accrued expenses and other current liabilities 57,094 1,261 5,923
Accrued compensation 32,606 2,021 8,961
Deferred revenue and deferred profit 0 0 (138)
Accrued price protection liability 34,719 (3,966) (5,117)
Lease liabilities (6,386) (8,142) 0
Other long-term liabilities (1,934) (394) (381)
Net cash provided by operating activities 73,593 78,348 102,689
Investing Activities      
Purchases of property and equipment (12,487) (6,887) (7,825)
Purchases of intangible assets (2,799) (86) 0
Cash used in acquisitions, net of cash acquired (160,000) 0 0
Net cash used in investing activities (175,286) (6,973) (7,825)
Financing Activities      
Net proceeds from the issuance of debt 175,000 0 0
Payment of debt issuance cost (2,696) 0 0
Repayment of debt (17,188) (50,000) (93,000)
Net proceeds from issuance of common stock 8,068 8,603 6,839
Minimum tax withholding paid on behalf of employees for restricted stock units (3,535) (11,986) (7,623)
Net cash provided by (used in) financing activities 159,649 (53,383) (93,784)
Effect of exchange rate changes on cash and cash equivalents (1,039) 934 (1,301)
Increase in cash, cash equivalents and restricted cash 56,917 18,926 (221)
Cash, cash equivalents and restricted cash at beginning of period 93,117 74,191 74,412
Cash, cash equivalents and restricted cash at end of period 150,034 93,117 74,191
Supplemental disclosures of cash flow information:      
Cash paid for interest 11,082 11,259 13,957
Cash paid for income taxes 2,822 4,417 5,426
Supplemental disclosures of non-cash investing and financing activities:      
Issuance of shares for payment of bonuses 3,258 7,632 6,997
Business Acquisition [Line Items]      
Inventory fair value adjustments 32,945 0 0
NanoSemi, Inc. [Member]      
Supplemental disclosures of non-cash investing and financing activities:      
Common stock issued in acquisitions, at fair value 17,080 0 0
Deferred payments of purchase price for acquisitions, at fair value $ 34,100 $ 0 $ 0

Source